Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
PhyeinMed was a Canadian medical cannabis company and Health Canada licensed producer based in British Columbia. The company developed indoor cultivation and processing capabilities in Falkland, BC, and was part of the corporate group that became Heritage Cannabis. Public disclosures indicate PhyeinMed progressed through the Canadian medical cannabis licensing process, received a cultivation licence in 2018, and later received standard processing and medical sales licences in 2019. Evidence from Canadian trademark records indicates the company name was changed from PhyeinMed Inc. to Voyage Cannabis Corp. in 2019. Based on the available records, PhyeinMed appears to have operated as a cannabis cultivation and processing subsidiary rather than a traditional biotech or pharmaceutical drug developer.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on PhyeinMed.